Monopar Therapeutics Inc Financial Overview
Monopar Therapeutics Inc's market cap is currently $458.63M. The company's EPS TTM is $-0.48; its P/E ratio is -20.62; Monopar Therapeutics Inc is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is $-0.45. See an overview of income statement, balance sheet, and cash flow financials.
